お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:いびき防止治療の世界市場 (2021-2027年):市場予測 (デバイス・流通経路別)・産業動向・地域的展望・用途の潜在性・価格動向・市場シェア
市場調査レポート
商品コード
1001594

いびき防止治療の世界市場 (2021-2027年):市場予測 (デバイス・流通経路別)・産業動向・地域的展望・用途の潜在性・価格動向・市場シェア

Anti-Snoring Treatment Market Size By Devices, By Distribution Channel, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 100 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.15円
いびき防止治療の世界市場 (2021-2027年):市場予測 (デバイス・流通経路別)・産業動向・地域的展望・用途の潜在性・価格動向・市場シェア
出版日: 2021年04月20日
発行: Global Market Insights Inc.
ページ情報: 英文 100 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

いびき防止治療の市場は、消費者のライフスタイルの変化に伴い、肥満やその他の健康問題が増加していることから、予測期間中大幅な成長を示すと予測されています。

また、高齢者人口の増加や、先進諸国や新興諸国を中心とした製品需要の高まりも同市場の動向を形成する要因となるでしょう。

デバイス別では、舌安定デバイスの部門が予測期間中8.5%のCAGRで成長すると予測されています。舌安定デバイスはいびきの問題や睡眠時無呼吸症に対するシンプルで費用対効果の高い非侵襲的なソリューションです。また、あごストラップの部門も、製品の使いやすさやより快適な製品の開発などから、今後数年で着実に成長すると予測されています。

当レポートでは、世界のいびき防止治療の市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、法規制環境、市場規模の推移・予測、デバイス・流通経路・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 調査手法・調査範囲

第2章 エグゼクティブサマリー

第3章 産業分析

  • 産業の分類
  • 産業情勢
  • 産業への影響要因
    • 成長要因
    • 潜在的リスク&課題
  • 成長の可能性
  • COVID-19:影響分析
  • 規制状況
  • ポーターの分析
  • 競合情勢
  • PESTEL分析

第4章 市場分析・予測:デバイス別

  • 下顎前進デバイス
  • 舌安定デバイス
  • 鼻用デバイス
  • 持続的気道陽圧法(CPAP)
  • あごストラップ
  • その他

第5章 市場分析・予測:流通経路別

  • 病院
  • クリニック
  • 小売薬局
  • Eコマース
  • その他

第6章 市場分析・予測:地域・主要国別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東
  • アフリカ

第7章 企業プロファイル

  • 競合ダッシュボード
  • Apnea Science
  • SomnoMed
  • Koninklijke Philips
  • The Pure Sleep Company
  • Airway Management Inc
  • Tomed GmBH
  • Meditas
  • GlaxoSmithKline Plc
  • Fisher & Paykel Healthcare
  • ResMed
  • Theravent (Foundation Consumer Healthcare)
  • The Pure Sleep Co (Sleep Science Partners, Inc)
  • Vyaire Medical
図表

Data Tables

  • TABLE 1 Anti-snoring treatment market, 2016-2027 (USD Million)
  • TABLE 2 Anti-snoring treatment market, by devices, 2016-2027 (USD Million)
  • TABLE 3 Anti-snoring treatment market, by distribution channel, 2016-2027 (USD Million)
  • TABLE 4 Anti-snoring treatment market, by region, 2016-2027 (USD Million)
  • TABLE 5 Industry impact forces
  • TABLE 6 Mandible advancement devices market size, by region, 2016-2027 (USD Million)
  • TABLE 7 Tongue stabilizing devices market size, by region, 2016-2027 (USD Million)
  • TABLE 8 Nasal devices market size, by region, 2016-2027 (USD Million)
  • TABLE 9 Continuous positive airways pressure devices market size, by region, 2016-2027 (USD Million)
  • TABLE 10 Chin straps market size, by region, 2016-2027 (USD Million)
  • TABLE 11 Others market size, by region, 2016-2027 (USD Million)
  • TABLE 12 Hospitals market size, by region, 2016-2027 (USD Million)
  • TABLE 13 Clinics market size, by region, 2016-2027 (USD Million)
  • TABLE 14 Retail pharmacies market size, by region, 2016-2027 (USD Million)
  • TABLE 15 E-commerce market size, by region, 2016-2027 (USD Million)
  • TABLE 16 Others market size, by region, 2016-2027 (USD Million)
  • TABLE 17 North America market size, by country, 2016 - 2027 (USD Million)
  • TABLE 18 North America market size, by device type, 2016 - 2027 (USD Million)
  • TABLE 19 North America market size, by distribution channel, 2016 - 2027 (USD Million)
  • TABLE 20 U.S. market size, by device type, 2016 - 2027 (USD Million)
  • TABLE 21 U.S. market size, by distribution channel, 2016 - 2027 (USD Million)
  • TABLE 22 Canada market size, by device type, 2016 - 2027 (USD Million)
  • TABLE 23 Canada market size, by distribution channel, 2016 - 2027 (USD Million)
  • TABLE 24 Europe market size, by country, 2016 - 2027 (USD Million)
  • TABLE 25 Europe market size, by device type, 2016 - 2027 (USD Million)
  • TABLE 26 Europe market size, by distribution channel, 2016 - 2027 (USD Million)
  • TABLE 27 Germany market size, by device type, 2016 - 2027 (USD Million)
  • TABLE 28 Germany market size, by distribution channel, 2016 - 2027 (USD Million)
  • TABLE 29 UK market size, by device type, 2016 - 2027 (USD Million)
  • TABLE 30 UK market size, by distribution channel, 2016 - 2027 (USD Million)
  • TABLE 31 France market size, by device type, 2016 - 2027 (USD Million)
  • TABLE 32 France market size, by distribution channel, 2016 - 2027 (USD Million)
  • TABLE 33 Italy market size, by device type, 2016 - 2027 (USD Million)
  • TABLE 34 Italy market size, by distribution channel, 2016 - 2027 (USD Million)
  • TABLE 35 Spain market size, by device type, 2016 - 2027 (USD Million)
  • TABLE 36 Spain market size, by distribution channel, 2016 - 2027 (USD Million)
  • TABLE 37 Asia Pacific market size, by country, 2016 - 2027 (USD Million)
  • TABLE 38 Asia Pacific market size, by device type, 2016 - 2027 (USD Million)
  • TABLE 39 Asia Pacific market size, by distribution channel, 2016 - 2027 (USD Million)
  • TABLE 40 Japan market size, by device, 2016 - 2027 (USD Million)
  • TABLE 41 Japan market size, by distribution channel, 2016 - 2027 (USD Million)
  • TABLE 42 China market size, by device, 2016 - 2027 (USD Million)
  • TABLE 43 China market size, by distribution channel, 2016 - 2027 (USD Million)
  • TABLE 44 India market size, by device, 2016 - 2027 (USD Million)
  • TABLE 45 India market size, by distribution channel, 2016 - 2027 (USD Million)
  • TABLE 46 Australia market size, by device, 2016 - 2027 (USD Million)
  • TABLE 47 Australia market size, by distribution channel, 2016 - 2027 (USD Million)
  • TABLE 48 Latin America market size, by country, 2016 - 2027 (USD Million)
  • TABLE 49 Latin America market size, by device, 2016 - 2027 (USD Million)
  • TABLE 50 Latin America market size, by distribution channel, 2016 - 2027 (USD Million)
  • TABLE 51 Brazil market size, by device, 2016 - 2027 (USD Million)
  • TABLE 52 Brazil market size, by distribution channel, 2016 - 2027 (USD Million)
  • TABLE 53 Brazil market size, by type, 2016 - 2027 (USD Million)
  • TABLE 54 Brazil market size, by age group, 2016 - 2027 (USD Million)
  • TABLE 55 Mexico market size, by device, 2016 - 2027 (USD Million)
  • TABLE 56 Mexico market size, by distribution channel, 2016 - 2027 (USD Million)
  • TABLE 57 MEA market size, by country, 2016 - 2027 (USD Million)
  • TABLE 58 MEA market size, by device, 2016 - 2027 (USD Million)
  • TABLE 59 MEA market size, by distribution channel, 2016 - 2027 (USD Million)
  • TABLE 60 South Africa market size, by device, 2016 - 2027 (USD Million)
  • TABLE 61 South Africa market size, by distribution channel, 2016 - 2027 (USD Million)
  • TABLE 62 Saudi Arabia market size, by device, 2016 - 2027 (USD Million)
  • TABLE 63 Saudi Arabia market size, by distribution channel, 2016 - 2027 (USD Million)

Charts & Figures

  • FIG. 1 Anti-snoring treatment industry 360 degree synopsis, 2016 - 2027
  • FIG. 2 Industry segmentation
  • FIG. 3 Global anti-snoring treatment industry landscape, 2016 - 2027 (USD Million)
  • FIG. 4 Growth potential analysis, by devices
  • FIG. 5 Growth potential analysis, by distribution channel
  • FIG. 6 Porter's analysis
  • FIG. 7 PESTEL analysis
  • FIG. 8 Key segment trends, by device
  • FIG. 9 Key segment trends, by distribution channel
  • FIG. 10 Key regional trends
  • FIG. 11 Competitive dashboard, 2020
目次
Product Code: 3998

Title:
Anti-Snoring Treatment Market Size By Devices (Mandible Advancement Devices, Tongue Stabilizing Devices, Nasal Devices, Continuous Positive Airway Pressure Devices, Chin Straps), By Distribution Channel (Hospitals, Clinics, Retail Pharmacies, E-commerce), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027.

The anti-snoring treatment market is expected to grow with a sizable CAGR by 2027 owing to changing consumer lifestyles, which have resulted in a rise in obesity and other health concerns. Additionally, increasing geriatric population, and escalating demand for anti-snoring devices, especially in developed and emerging economies, would also shape industry trends.

As there is no certain cure for snoring, consumers have been seen resorting to different types of anti-snoring devices to reduce or prevent snoring. Industry players offer a wide range of products that can help people stop snoring. Consumers get several options to choose from depending on their individual preferences.

The development of innovative and more comfortable anti-snoring devices is expected to boost the demand for the market in the following years.

The anti-snoring treatment market has been segmented based on device, distribution channel, and region.

Based on device, the tongue stabilizing devices sub-segment is projected to grow with a CAGR of 8.5% through the analysis period. A tongue stabilizing device is a simple, cost-effective and, non-invasive solution to snoring problem and sleep apnea.

The chin straps sub-segment is expected to grow steadily in the coming years due to the easy-to-use attributes of these products and the development of new, more comfortable chin straps by companies.

Based on distribution channel, the clinics sub-segment held a notable 17% share in the anti-snoring treatment market in 2020. The sub-segment is estimated to see sturdy growth in the coming years due to the easy availability of low-cost anti-snoring devices in clinics, contributing substantially to the growth of the global market.

Based on region, North America is expected to see considerable growth in the assessment period. The United States anti-snoring treatment market was valued at over USD 1.8 billion in 2020.

The presence of major players in the country, coupled with the rising obese population and increasing awareness regarding anti-snoring devices, is projected to drive the market growth in the North American region.

The anti-snoring treatment market in Latin America is also speculated to deliver notable gains by 2027 with a sizable CAGR, driven by the surge in the presence of market entrants along with established players in the region and the increased demand and availability of anti-snoring devices that are comfortable as well as affordable.

Researchers and companies have been focusing on developing more compact anti-snoring devices that can effectively prevent snoring.

Recently, Professor Joerg Steier of King's College London, a renowned sleep expert, has collaborated with Morgan Innovation & Technology to launch a crowdfunding initiative for an anti-snoring device named 'ZEUS.'

ZUES, which has been described as a sleek and non-invasive solution to stop snoring, targets the throat muscles that cause snoring. The device tightens the tongue muscle and keeps the airways open without disrupting the sleep of the user.

A 2020 paper titled 'The anti-snoring bed - a pilot study' published in Sleep Science and Practice studied the functioning of an anti-snoring bed. The researchers found that the bed was able to stop individual incidents of habitual snoring without compromising the subjective sleep quality.

Table of Contents

Chapter 1 Methodology

  • 1.1 Market definitions
  • 1.2 Base estimates and working
    • 1.2.1 North America
    • 1.2.2 Europe
    • 1.2.3 Asia Pacific
    • 1.2.4 Latin America
    • 1.2.5 MEA
  • 1.3 Forecast calculations
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Anti-snoring treatment market industry 360 degree synopsis
    • 2.1.1 Business trends
    • 2.1.2 Device type trends
    • 2.1.3 Distribution channel trends
    • 2.1.4 Regional trends

Chapter 3 Anti-snoring Treatment Market Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2016 - 2027 (USD Million)
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Rising geriatric and obese people
      • 3.3.1.2 Growing cigarette and alcohol consumption
      • 3.3.1.3 Technological advancement in anti-snoring devices
      • 3.3.1.4 Increasing prevalence of sleep disorder
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 High cost of devices
      • 3.3.2.2 Lack of reimbursement policies
  • 3.4 Growth potential analysis
    • 3.4.1 By device
    • 3.4.2 By distribution channel
  • 3.5 COVID-19 impact analysis
  • 3.6 Regulatory landscape
  • 3.7 Porter's analysis
  • 3.8 Competitive landscape, 2020
  • 3.9 PESTEL analysis

Chapter 4 Anti-snoring Treatment Market, By Device

  • 4.1 Key segment trends
  • 4.2 Mandible advancement devices
    • 4.2.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.3 Tongue stabilizing devices
    • 4.3.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.4 Nasal devices
    • 4.4.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.5 Continuous positive airway pressure (CPAP)
    • 4.5.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.6 Chin straps
    • 4.6.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.7 Others
    • 4.7.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 5 Anti-snoring Treatment Market, By Distribution Channel

  • 5.1 Key segment trends
  • 5.2 Hospitals
    • 5.2.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.3 Clinics
    • 5.3.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.4 Retail pharmacies
    • 5.4.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.5 E-commerce
    • 5.5.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.6 Others
    • 5.6.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 6 Anti-snoring Treatment Market, By Region

  • 6.1 Key regional trends
  • 6.2 North America
    • 6.2.1 Market size, by country, 2016 - 2027 (USD Million)
    • 6.2.2 Market size, by devices, 2016 - 2027 (USD Million)
    • 6.2.3 Market size, by distribution channel, 2016-2027 (USD Million)
    • 6.2.4 U.S.
      • 6.2.4.1 Market size, by devices, 2016 - 2027 (USD Million)
      • 6.2.4.2 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 6.2.5 Canada
      • 6.2.5.1 Market size, by devices, 2016 - 2027 (USD Million)
      • 6.2.5.2 Market size, by distribution channel, 2016 - 2027 (USD Million)
  • 6.3 Europe
    • 6.3.1 Market size, by country, 2016 - 2027 (USD Million)
    • 6.3.2 Market size, by devices, 2016 - 2027 (USD Million)
    • 6.3.3 Market size, by distribution channel, 2016-2027 (USD Million)
    • 6.3.4 Germany
      • 6.3.4.1 Market size, by devices, 2016 - 2027 (USD Million)
      • 6.3.4.2 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 6.3.5 UK
      • 6.3.5.1 Market size, by devices, 2016 - 2027 (USD Million)
      • 6.3.5.2 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 6.3.6 France
      • 6.3.6.1 Market size, by devices, 2016 - 2027 (USD Million)
      • 6.3.6.2 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 6.3.7 Spain
      • 6.3.7.1 Market size, by devices, 2016 - 2027 (USD Million)
      • 6.3.7.2 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 6.3.8 Italy
      • 6.3.8.1 Market size, by devices, 2016 - 2027 (USD Million)
      • 6.3.8.2 Market size, by distribution channel, 2016 - 2027 (USD Million)
  • 6.4 Asia Pacific
    • 6.4.1 Market size, by country, 2016 - 2027 (USD Million)
    • 6.4.2 Market size, by devices, 2016 - 2027 (USD Million)
    • 6.4.3 Market size, by distribution channel, 2016-2027 (USD Million)
    • 6.4.4 Japan
      • 6.4.4.1 Market size, by devices, 2016 - 2027 (USD Million)
      • 6.4.4.2 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 6.4.5 China
      • 6.4.5.1 Market size, by devices, 2016 - 2027 (USD Million)
      • 6.4.5.2 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 6.4.6 India
      • 6.4.6.1 Market size, by devices, 2016 - 2027 (USD Million)
      • 6.4.6.2 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 6.4.7 Australia
      • 6.4.7.1 Market size, by devices, 2016 - 2027 (USD Million)
      • 6.4.7.2 Market size, by distribution channel, 2016 - 2027 (USD Million)
  • 6.5 Latin America
    • 6.5.1 Market size, by country, 2016 - 2027 (USD Million)
    • 6.5.2 Market size, by devices, 2016 - 2027 (USD Million)
    • 6.5.3 Market size, by distribution channel, 2016-2027 (USD Million)
    • 6.5.4 Brazil
      • 6.5.4.1 Market size, by devices, 2016 - 2027 (USD Million)
      • 6.5.4.2 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 6.5.5 Mexico
      • 6.5.5.1 Market size, by devices, 2016 - 2027 (USD Million)
      • 6.5.5.2 Market size, by distribution channel, 2016 - 2027 (USD Million)
  • 6.6 Middle East & Africa
    • 6.6.1 Market size, by country, 2016 - 2027 (USD Million)
    • 6.6.2 Market size, by devices, 2016 - 2027 (USD Million)
    • 6.6.3 Market size, by distribution channel, 2016-2027 (USD Million)
    • 6.6.4 Saudi Arabia
      • 6.6.4.1 Market size, by devices, 2016 - 2027 (USD Million)
      • 6.6.4.2 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 6.6.5 South Africa
      • 6.6.5.1 Market size, by devices, 2016 - 2027 (USD Million)
      • 6.6.5.2 Market size, by distribution channel, 2016 - 2027 (USD Million)

Chapter 7 Company Profiles

  • 7.1 Competitive dashboard, 2020
  • 7.2 Apnea Science
    • 7.2.1 Business overview
    • 7.2.2 Financial data
    • 7.2.3 Product landscape
    • 7.2.4 Strategic outlook
    • 7.2.5 SWOT analysis
  • 7.3 SomnoMed
    • 7.3.1 Business overview
    • 7.3.2 Financial data
    • 7.3.3 Product landscape
    • 7.3.4 Strategic outlook
    • 7.3.5 SWOT analysis
  • 7.4 Koninklijke Philips
    • 7.4.1 Business overview
    • 7.4.2 Financial data
    • 7.4.3 Product landscape
    • 7.4.4 Strategic outlook
    • 7.4.5 SWOT analysis
  • 7.5. The Pure Sleep Company
    • 7.5.1 Business overview
    • 7.5.2 Financial data
    • 7.5.3 Product landscape
    • 7.5.4 Strategic outlook
    • 7.5.5 SWOT analysis
  • 7.6 Airway Management Inc
    • 7.6.1 Business overview
    • 7.6.2 Financial data
    • 7.6.3 Product landscape
    • 7.6.4 Strategic outlook
    • 7.6.5 SWOT analysis
  • 7.7 Tomed GmBH
    • 7.7.1 Business overview
    • 7.7.2 Financial data
    • 7.7.3 Product landscape
    • 7.7.4 Strategic outlook
    • 7.7.5 SWOT analysis
  • 7.8 Meditas
    • 7.8.1 Business overview
    • 7.8.2 Financial data
    • 7.8.3 Product landscape
    • 7.8.4 Strategic outlook
    • 7.8.5 SWOT analysis
  • 7.9 GlaxoSmithKline Plc
    • 7.9.1 Business overview
    • 7.9.2 Financial data
    • 7.9.3 Product landscape
    • 7.9.4 Strategic outlook
    • 7.9.5 SWOT analysis
  • 7.10 Fisher & Paykel Healthcare
    • 7.10.1 Business overview
    • 7.10.2 Financial data
    • 7.10.3 Product landscape
    • 7.10.4 Strategic outlook
    • 7.10.5 SWOT analysis
  • 7.11 ResMed
    • 7.11.1 Business overview
    • 7.11.2 Financial data
    • 7.11.3 Product landscape
    • 7.11.4 Strategic outlook
    • 7.11.5 SWOT analysis
  • 7.12 Theravent (Foundation Consumer Healthcare)
    • 7.12.1 Business overview
    • 7.12.2 Financial data
    • 7.12.3 Product landscape
    • 7.12.4 Strategic outlook
    • 7.12.5 SWOT analysis
  • 7.13 The Pure Sleep Co (Sleep Science Partners, Inc)
    • 7.13.1 Business overview
    • 7.13.2 Financial data
    • 7.13.3 Product landscape
    • 7.13.4 Strategic outlook
    • 7.13.5 SWOT analysis
  • 7.14 Vyaire Medical
    • 7.14.1 Business overview
    • 7.14.2 Financial data
    • 7.14.3 Product landscape
    • 7.14.4 Strategic outlook
    • 7.14.5 SWOT analysis
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.